L’Occitane’s Americas business has benefitted from its recent acquisition of Brazil-inspired beauty brand Sol de Janeiro.
The group released its unaudited quarterly update for the three months ended 30 June 2022 (FY2023 Q1) today, revealing that its sales in the Americas grew 55.5% at constant rates thanks to the brand’s inclusion and the continued reopening of markets.
L’Occitane says Sol de Janeiro ended FY2023 Q1 with €40.8m in sales, an increase of 60% in local currency as compared with the same quarter last year, prior to the acquisition.
The brand’s international growth is attributed to the successful global launches of its Beija Flor range and premium perfume mists, together with further expansion outside the US.
Overall, L’Occitane sales for the period grew 15.8%. On a like-for-like basis, excluding Sol de Janeiro and fellow newcomer Grown Alchemist, as well as the group’s recently divested Russia business and the deconsolidation of its US subsidiary, sales growth was 5.1%.
The group’s core L’Occitane en Provence brand grew 5.9% at constant rates in FY2023 Q1, despite very strong 36.1% growth at constant rates in FY2022 Q1 as the base.
Elemis sales, meanwhile, increased 9.8%, with key contributions from US and international roll-outs.
L’Occitane’s other brands – Erborian, L’Occitane au Brésil and LimeLife – together posted a 3.4% decline at constant rates.
Sales of LimeLife were affected by the decrease in beauty guides (LimeLife’s community of representatives) and ended the quarter with a double-digit decline.
According to L’Occitane, LimeLife revamped its commission structure during the quarter to drive regular recruitment of new beauty guides.
